Protective effect of anthocyanin-rich extract from bilberry (Vaccinium myrtillus L.) against myelotoxicity induced by 5-fluorouracil

BioFactors

Volumn 29, Issue 1, 2007, Pages 55-65

  Choi, Eun Hye ^a   Ok, Hyun Ee ^a   Yoon, Yoosik ^b   Magnuson, Bernadene A ^c   Kim, Mi Kyung ^d   Chun, Hyang Sook ^a  

^a Korea Food Research Institute   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^c UNIVERSITY OF MARYLAND   (United States)

^d Ewha Womans University   (South Korea)

Author keywords

5 fluorouracil; Anthocyanin; Bilberry; Chemotherapeutic efficacy; Myelotoxicity

Indexed keywords

FLUOROURACIL; VACCINIUM MYRTILLUS ANTHOCYANOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW TOXICITY; CHEMOPROPHYLAXIS; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; ERYTHROCYTE COUNT; ERYTHROPENIA; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VACCINIUM MYRTILLUS;

ADMINISTRATION, ORAL; ANIMALS; ANTHOCYANINS; BONE MARROW CELLS; CELL COUNT; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FLUOROURACIL; HT29 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; PLANT EXTRACTS; SPLEEN; TIME FACTORS; VACCINIUM MYRTILLUS;

MUS; VACCINIUM MYRTILLUS;

EID: 34250808416     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520290106     Document Type: Article

References (38)

1. D. Adeyemo, F. Imtiaz, S. Toffa, M. Lowdell, R.G.Wickremasinghe and M.Winslet, Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein, Cancer Lett 164 (2001), 77-84.
2. D. Bagchi, A. Garg, R.L. Krohn, M. Bagchi, D.J. Bagchi, J. Balmoori and S.J. Stohs, Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice, Gen Pharmacol 30 (1998), 771-776.
3. R. Chinery, J.A. Brockman, M.O. Peeler, Y. Shyr, R.D. Beauchamp and R.J. Coffey, Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta, Nat Med 3 (1997), 1233-1241.
4. K.A. Conklin, Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects, Nutr Cancer 37 (2000), 1-18.
5. G.Y. Deng, Y.W. Liu, G.Z. He and Z.M. Jiang, Effect of dietary fiber on intestinal barrier function of 5-Fu stressed rats, Res Exp Med 199 (1999), 111-119.
6. R.B. Diasio and B.E. Harris, Clinical pharmacology of 5-fluorouracil, Clin Pharmacokinet 16 (1989), 215-237.
7. R.W. Durst and R.E, Wrolstad, Separation and characterization of anthocyanins by HPLC, in: Current Protocols in Food Analytical Chemistry, R.E. Wrolstad, ed., John Wiley & Sons, New York, 2001, pp. F1.3.1-F1.3.13.
8. M.M. Giusti and R.E. Wrolstad, Characterization and measurement of anthocyanins by UV-Visible spectroscopy, in: Current Protocols in Food Analytical Chemistry, R.E. Wrolstad, ed., John Wiley & Sons, New York, 2001, pp. F1.2.1-F1.2.13.
9. M.M. Giusti and R.E. Wrolstad, Characterization of red radish anthocyanins, J Food Sci 61 (1996), 322-326.
10. J.L. Grem, D.F. Hoth, J.M. Hamilton, S.A. King and B. Leyland-Jones, Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid, Cancer Treat Rep 71 (1987), 1249-1264.
11. A. Hagiwara A., H. Yoshino, T. Ichihara, M. Kawabe, S. Tomano, H. Aoki, M. Nakamura, K. Imaida, N. Ito and T. Shirai, Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine, J Toxicol Sci 27 (2002), 57-68.
12. G.K. Harris, A. Gupta, R.G. Nines, L.A. Kresty, S.G. Habib, W.L. Frankel, K. LaPerle, D.D. Gallaher, S.J. Schwartz and G.D. Stoner, Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rats, Nutr Cancer 40 (2001), 125-133.
13. S.D. Harrison, E.P. Denine and J.C. Peckham, Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice, Cancer Treat Rep 62 (1978), 533-545.
14. M. Hejna, W.J. Kostler, M. Raderer, S. Tomek, T. Brodowicz, W. Scheithauer, C. Wiltschke and C.C. Zielinski, Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer, Anticancer Drugs 11 (2000), 629-634.
15. J.A. Houghton, P.J. Houghton and R.S. Wooten, Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2′-deoxyuridine, Cancer Res 39 (1979), 2406-2413.
16. D.J. Jodrell, M. Stewart, R. Aird, G. Knowles, A. Bowman, L. Wall, J. Cummings and C. Mclean, 5-Fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer, Br J Cancer 84 (2001), 600-603.
17. H. Kamei, Y. Hashimoto, T. Koide, T. Kojima and M. Hasegawa, Anti-tumor effect of methanol extracts form red and white wines, Cancer Biother Radiopharm 13 (1998), 447-452.
18. S.Y. Kang, N.P. Seeram, M.G. Nair and L.D. Bourquin, Tart cherry anthocyanins inhibit tumor development in Apc (Min) mice and reduce proliferation of human colon cancer cells, Cancer Lett 194 (2003), 13-19.
19. S. Kojima, K. Takaba, N. Kimoto, T. Takeda, M. Kakuni, M. Mizutani, K. Suzuki, H. Sato and T. Hara, Protective effects of glutathione on 5-fluorouracil-induced myelosuppression in mice, Arch Toxicol 77 (2003), 285-290.
20. C. Kucuk, M. Ozkan, H. Akgun, S. Muhtaroglu and E. Sozuer, The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats, J Surg Res 128 (2005), 15-20.
21. M.C. Lazzé, R. Pizzala, M. Savio, L.A. Stivala, E. Prosperi and L. Bianchi, Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells, Mutat Res 535 (2003), 103-115.
22. I.C. Macdougall and A.C. Cooper, Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines, Nephrol Dial Transplant 17 (2002), 39-43.
23. T. Mas, J. Susperregui, B. Berke, C. Cheze, S. Moreau, A. Nuhrich and J. Vercauteren, DNA triplex stabilization property of natural anthocyanins, Phytochemistry 53 (2000), 679-687.
24. P.E. Milbury, G. Cao, R.L. Prior and J. Blumberg, Bioavailablility of elderberry anthocyanins, Mech Ageing Dev 123 (2002), 997-1006.
25. K. Ohgami, I. Ilieva, K. Shiratori, Y. Koyama, X.H. Jin, K. Yoshida, S. Kase, N. Kitaichi, Y. Suzuki, T. Tanaka and S. Ohno, Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis, Invest Ophthalmol Vis Sci 46 (2005), 275-281.
26. C. Pergola, A. Rossi, P. Dugo, S. Cuzzocrea and L. Sautebin, Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract, Nitric Oxide 15 (2006), 30-39.
27. G.D. Roodman, A. Bird, D. Hutzler and W. Montgomery, Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on growth of erythroid progenitors CFU-E and BFU-E and hematopoietic cell lines K562, HL60, and HEL cells, Exp Hematol 15 (1987), 928-935.
28. A.D. Sarma and R. Sharma, Anthocyanin-DNA copigmentation complex: mutual protection against oxidative damage, Phytochemistry 52 (1999), 1313-1318.
29. J.D. Schuetz, H.J.Wallace and R.B. Diasio, 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity, Cancer Res 44 (1984), 1358-1363.
30. R. Sharma, P. Tobin and S.J. Clarke, Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhea, Lancet Oncol 6 (2005), 93-102.
31. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney and M.R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J Natl Cancer Inst 82 (1990), 1107-1112.
32. S. Subramaniam, S. Subramaniam and C.S. Shyamala Devi, Vitamin E protects intestinal basolateral membrane from CMF-induced damages in rat, Indian J Physiol Pharmacol 39 (1995), 263-266.
33. F. Takano, T. Tanaka, E. Tsukamoto, N. Yahagi and S. Fushiya, Isolation of (+)-catechin and (?)-epicatechin from Actinidia arguta as bone marrow cell proliferation promoting compounds, Planta Med 69 (2003), 321-326.
34. F. Takatsuki, Y. Miyasaka, T. Kikuchi, M. Suzuki and J. Hamuro, Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents, Exp Hematol 24 (1996), 416-422.
35. A. Tomiak, M. Vincent, W. Kocha, M. Taylor, E. Winquist, M. Sawyer, S. Griffeth, F. Whiston and L. Stitt, Standard dose (Mayo regimen) 5-fluorouracil and low does folinic acid: prohibitive toxicity? Am J Clin Oncol 23 (2000), 94-98.
36. R.S. White, W.B. Fuqua and O. Barrett, The effect of 5-fluorouracil on small bowel mucosa, J Surg Oncol 3 (1971), 501-506.
37. X. Ye, R.L. Krohn, W. Liu, S.S. Joshi, C.A. Kuszynski, T.R. McGinn, M. Bagchi, H.G. Preuss, S.J. Stohs and D. Bagchi, The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells, Mol Cell Biochem 196 (1999), 99-108.
38. C. Zhao, M.M. Giusti, M. Malik, M.P. Moyer and B.A. Magnuson, Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth, J Agric Food Chem 52 (2004), 6122-6128.